MR enterography ‘valid option for young Crohn’s patients’

23 August 2012

MR enterography is a valid option for young patients with Crohn’s disease, according to new research.

Children who have inflammatory bowel disease tend to have a lot of x-rays and CT, which could result in significant radiation exposure.

MR enterography, on the other hand, does not require radiation. However, the patient does need to drink an oral contrast agent, hold their breath and stay still during the examination.

While this could be difficult for young children, those over the age of nine could potentially be examined in this way, scientists said.

MR enterography was found to perform as well in children as it did in adults, and could correctly identify inflammation 80 per cent of the time in the terminal ileum, 79 per cent of the time in the right colon, and 90 per cent in the left colon.

Patients’ tolerance to the procedure was seen to be linked to the amount of contrast the patient was asked to drink, and it was found that younger children could consume a smaller amount without negatively affecting the image quality.

Posted by Jeanette Royston

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...


Diagnostic imaging

© Spire Healthcare Group plc (2016)